What are the recommended insulin dosing guidelines for a patient with diabetes?

Insulin Dosing Guidelines

Initial Dosing for Type 2 Diabetes

For insulin-naive patients with type 2 diabetes, start with 10 units of basal insulin once daily OR 0.1-0.2 units/kg body weight, administered at the same time each day. 1, 2, 3

• Continue metformin (unless contraindicated) when initiating insulin therapy, as this combination reduces total insulin requirements and limits weight gain compared to insulin alone 1, 2, 4
• For patients with severe hyperglycemia (A1C ≥9%, blood glucose ≥300-350 mg/dL, or symptomatic/catabolic features), consider higher starting doses of 0.3-0.5 units/kg/day using a basal-bolus regimen from the outset 1, 2, 4
• Administer subcutaneously into the abdominal area, thigh, or deltoid, rotating injection sites within the same region to reduce lipodystrophy risk 3

Initial Dosing for Type 1 Diabetes

For type 1 diabetes, start with a total daily dose of 0.5 units/kg/day, divided as approximately 50% basal insulin and 50% prandial insulin split among three meals. 1, 2, 5

• Total daily insulin requirements typically range from 0.4-1.0 units/kg/day for metabolically stable patients 1, 2
• Higher doses are required during puberty, pregnancy, and acute illness, potentially exceeding 1.0 units/kg/day 1
• Patients in the honeymoon phase may require lower doses of 0.2-0.6 units/kg/day 1

Titration Algorithm

Increase basal insulin by 2 units every 3 days if fasting glucose is 140-179 mg/dL, and by 4 units every 3 days if fasting glucose is ≥180 mg/dL, until reaching target fasting glucose of 80-130 mg/dL. 1, 2, 4

• If hypoglycemia occurs without clear cause, reduce the dose by 10-20% immediately 1, 2
• Daily fasting blood glucose monitoring is essential during titration 1, 2
• Reassess every 3 days during active titration and every 3-6 months once stable 1

Critical Threshold: When to Add Prandial Insulin

When basal insulin exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day, add prandial insulin rather than continuing to escalate basal insulin alone. 1, 2

• Clinical signals of "overbasalization" include: basal dose >0.5 units/kg/day, bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, and high glucose variability 1, 2
• Start prandial insulin with 4 units of rapid-acting insulin before the largest meal OR 10% of the current basal dose 1, 2
• Titrate prandial insulin by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose readings 1, 2
• Add prandial insulin if basal insulin has been optimized (fasting glucose 80-130 mg/dL) but A1C remains above target after 3-6 months 1, 2

Hospitalized Patients

For hospitalized patients, initiate insulin therapy at a threshold ≥180 mg/dL (checked on two occasions), targeting a glucose range of 140-180 mg/dL for most critically ill and noncritically ill patients. 6

• For insulin-naive or low-dose insulin patients, start with 0.3-0.5 units/kg/day total daily dose, with half as basal insulin 2
• For patients on high-dose home insulin (≥0.6 units/kg/day), reduce the total daily dose by 20% upon admission to prevent hypoglycemia 1, 2
• Use lower doses (0.1-0.25 units/kg/day) for high-risk patients: elderly (>65 years), renal failure, or poor oral intake 1, 2
• Point-of-care glucose monitoring should be performed before meals for eating patients, or every 4-6 hours for non-eating patients 6

Special Population Adjustments

For patients with chronic kidney disease stage 5 and type 2 diabetes, reduce total daily insulin dose by 50%; for type 1 diabetes with CKD stage 5, reduce by 35-40%. 1

• Elderly patients or those with renal impairment should start at the lower end (0.1 units/kg/day) to minimize hypoglycemia risk 1
• During perioperative periods, reduce insulin dose by approximately 25% the evening before surgery 1
• For patients on steroids, increase prandial and correction insulin by 40-60% or more in addition to basal insulin 1

Converting from Other Insulin Regimens

When switching from twice-daily NPH to once-daily basal insulin, use 80% of the total NPH dose to prevent hypoglycemia. 1, 4, 3

• When switching from once-daily NPH to once-daily basal insulin, use the same dose 3
• When switching from TOUJEO (insulin glargine 300 units/mL) to Lantus (insulin glargine 100 units/mL), use 80% of the TOUJEO dose 3
• When converting from glargine to detemir, the total daily dose of detemir should be approximately 38% higher than glargine 1

Critical Pitfalls to Avoid

Never use sliding scale insulin as monotherapy—it is explicitly condemned by all major diabetes guidelines and shown to be ineffective. 1

• Do not delay insulin initiation in patients not achieving glycemic goals with oral medications, as this prolongs hyperglycemia exposure and increases complication risk 1, 2
• Never discontinue metformin when starting insulin unless contraindicated, as this leads to higher insulin requirements and more weight gain 1, 2, 4
• Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as this leads to overbasalization with increased hypoglycemia risk 1, 2
• Avoid using premixed insulins in hospitalized patients due to unacceptably high rates of iatrogenic hypoglycemia 1, 4
• Never dilute or mix insulin glargine with any other insulin or solution 3
• Do not administer insulin glargine intravenously or via an insulin pump 3

Patient Education Essentials

Teach recognition and treatment of hypoglycemia: treat at blood glucose ≤70 mg/dL with 15 grams of fast-acting carbohydrate. 1

• Educate on proper insulin injection technique and site rotation to prevent lipohypertrophy 1, 7
• Instruct on self-monitoring of blood glucose, "sick day" management rules, and insulin storage and handling 1
• Equip patients with self-titration algorithms based on fasting glucose readings to improve glycemic control 1, 2
• The shortest needles (4-mm pen and 6-mm syringe needles) are safe, effective, less painful, and should be first-line choice 7